Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease-Reply

JAMA. 2016 Dec 6;316(21):2276-2277. doi: 10.1001/jama.2016.16751.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / drug therapy
  • Decision Making
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Primary Prevention*

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin